EGFR expression levels affect the mode of action of egfr-targeting monoclonal antibodies

Stefanie Derer; Stefan Lohse; Thomas Valerius

doi:10.4161/onci.24052

EGFR expression levels affect the mode of action of egfr-targeting monoclonal antibodies

Stefanie Derer, Stefan Lohse, Thomas Valerius^*

^*Korrespondierende/r Autor/-in für diese Arbeit

Institut für Ernährungsmedizin

Christian-Albrechts Universität zu Kiel

7 Zitate (Scopus)

Abstract

Epidermal growth factor receptor (EGFR) expression levels appear to modulate the efficacy of EGFR-targeting monoclonal antibodies. More specifically, we observed that high EGFR densities negatively affect the effects of EGFRspecific antibodies on EGFR phosphorylation yet exacerbate Fc-mediated tumor-cell killing. These results suggest that the predominant mode of action of EGFR-targeting antibodies depend on EGFR expression levels.

Originalsprache	Englisch
Aufsatznummer	e24052
Zeitschrift	OncoImmunology
Jahrgang	2
Ausgabenummer	5
ISSN	2162-4011
DOIs	https://doi.org/10.4161/onci.24052
Publikationsstatus	Veröffentlicht - 05.2013

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Dokumente

10.4161/onci.24052

Weitere Links

Link to publication in Scopus

Zitieren

@article{459a5d18094945ebb8a77ceeaae8db4c,

title = "EGFR expression levels affect the mode of action of egfr-targeting monoclonal antibodies",

abstract = "Epidermal growth factor receptor (EGFR) expression levels appear to modulate the efficacy of EGFR-targeting monoclonal antibodies. More specifically, we observed that high EGFR densities negatively affect the effects of EGFRspecific antibodies on EGFR phosphorylation yet exacerbate Fc-mediated tumor-cell killing. These results suggest that the predominant mode of action of EGFR-targeting antibodies depend on EGFR expression levels.",

author = "Stefanie Derer and Stefan Lohse and Thomas Valerius",

year = "2013",

month = may,

doi = "10.4161/onci.24052",

language = "English",

volume = "2",

journal = "OncoImmunology",

issn = "2162-4011",

publisher = "Taylor and Francis Ltd.",

number = "5",

}

TY - JOUR

T1 - EGFR expression levels affect the mode of action of egfr-targeting monoclonal antibodies

AU - Derer, Stefanie

AU - Lohse, Stefan

AU - Valerius, Thomas

PY - 2013/5

Y1 - 2013/5

N2 - Epidermal growth factor receptor (EGFR) expression levels appear to modulate the efficacy of EGFR-targeting monoclonal antibodies. More specifically, we observed that high EGFR densities negatively affect the effects of EGFRspecific antibodies on EGFR phosphorylation yet exacerbate Fc-mediated tumor-cell killing. These results suggest that the predominant mode of action of EGFR-targeting antibodies depend on EGFR expression levels.

AB - Epidermal growth factor receptor (EGFR) expression levels appear to modulate the efficacy of EGFR-targeting monoclonal antibodies. More specifically, we observed that high EGFR densities negatively affect the effects of EGFRspecific antibodies on EGFR phosphorylation yet exacerbate Fc-mediated tumor-cell killing. These results suggest that the predominant mode of action of EGFR-targeting antibodies depend on EGFR expression levels.

UR - https://www.scopus.com/pages/publications/84886945205

U2 - 10.4161/onci.24052

DO - 10.4161/onci.24052

M3 - Journal articles

AN - SCOPUS:84886945205

SN - 2162-4011

VL - 2

JO - OncoImmunology

JF - OncoImmunology

IS - 5

M1 - e24052

ER -

EGFR expression levels affect the mode of action of egfr-targeting monoclonal antibodies

Abstract

UN SDGs

Strategische Forschungsbereiche und Zentren

Dokumente

Weitere Links

Fingerprint

Zitieren